NCT07021950 2025-06-15AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal CancerSun Yat-sen UniversityPhase 2 Not yet recruiting130 enrolled